ArticleDiscover oncology2025
The optimal number of examined lymph nodes for cancer specific death of intrahepatic cholangiocarcinoma: a population-based study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe number of lymph nodes to be removed during tumor resection in patients with intrahepatic cholangiocarcinoma (ICC) has always been a subject of controversy. The correlation between examined lymph nodes (ELN) and cancer-specific mortality (CSM) in individuals with ICC was the purpose of this investigation.
methodsMultivariable models were used to analyze data from the Surveillance, Epidemiology, and End Results database on ICC in order to ascertain the connection between ELN count and CSM. Correlation between ELN and cancer-specific survival (CSS) was evaluated by restricted cubic splines (RCS) on a continuous scale. Locally weighted scatterplot smoothing smoother was used to evaluated the hazard ratios (HRs) of ELNs for CSS with the structural breakpoints determined by Chow test.
resultsThis investigation incorporated 1335 ICC cases. Independent risk factors for CSM included median household income, race, diagnostic year, tumor grade, clinical stage, pT stage, pN stage, pM stage and ELN count. With the adjustment for covariates, ICC cases showed statistically significant improvements in CSS (HR = 0.88) as the ELN count increased. The best threshold ELN count, as determined by cut-point analysis, was 6, which allowed for accurate CSS probability discrimination.
conclusionIncreasing ELN count indicated better CSS. Our results strongly suggested 6 ELNs as the optimal cut-off number for assessing the standard of lymph node inspection and prognostic classification in ICC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.